Volume 59, Issue 6 pp. 2174-2175
LETTER TO THE EDITOR

Response to “Be alert to leukocyte antibodies when prescribing granulocyte transfusions”

Thomas H. Price

Thomas H. Price

Department of Medicine, University of Washington, Seattle, Washington

Bloodworks Northwest, Seattle, Washington

Search for more papers by this author
Jeffrey McCullough

Jeffrey McCullough

Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, Minnesota

Search for more papers by this author
Ronald G. Strauss

Ronald G. Strauss

Department of Pathology, University of Iowa Hospital, Iowa City, Iowa

LifeSource/ITxM, Chicago, Illinois

Search for more papers by this author
Paul M Ness

Paul M Ness

Department of Pathology, Division of Transfusion Medicine, Johns Hopkins Hospital, Baltimore, Maryland

Search for more papers by this author
Taye H. Hamza

Taye H. Hamza

New England Research Institutes, Watertown, Massachusetts

Search for more papers by this author
Ryan W. Harrison

Ryan W. Harrison

Corrona LLC, Waltham, Massachusetts

Search for more papers by this author
Susan F. Assmann

Susan F. Assmann

New England Research Institutes, Watertown, Massachusetts

Search for more papers by this author
First published: 03 June 2019
No abstract is available for this article.

CONFLICT OF INTEREST

The authors have disclosed no conflicts of interest.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.